El-Tanani MK - Search Results

1

RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin.

Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, Campbell FC, Anderson IP, Rudland PS, El-Tanani MK. Kurisetty VV, et al. Among authors: el tanani mk. Oncogene. 2008 Dec 4;27(57):7139-49. doi: 10.1038/onc.2008.325. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794800

2

Regulatory region of metastasis-inducing DNA is the binding site for T cell factor-4.

El-Tanani MK, Barraclough R, Wilkinson MC, Rudland PS. El-Tanani MK, et al. Oncogene. 2001 Mar 29;20(14):1793-7. doi: 10.1038/sj.onc.1204358. Oncogene. 2001. PMID: 11313926

3

Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.

El-Tanani M, Barraclough R, Wilkinson MC, Rudland PS. El-Tanani M, et al. Cancer Res. 2001 Jul 15;61(14):5619-29. doi: 10.1100/tsw.2002.238. Cancer Res. 2001. PMID: 11454716

4

Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors.

El-Tanani M, Fernig DG, Barraclough R, Green C, Rudland P. El-Tanani M, et al. J Biol Chem. 2001 Nov 9;276(45):41675-82. doi: 10.1074/jbc.M103966200. Epub 2001 Aug 24. J Biol Chem. 2001. PMID: 11522780 Free article.

5

Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.

Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR. Rudland PS, et al. Cancer Res. 2002 Jun 15;62(12):3417-27. Cancer Res. 2002. PMID: 12067984

6

Ets gene PEA3 cooperates with beta-catenin-Lef-1 and c-Jun in regulation of osteopontin transcription.

El-Tanani M, Platt-Higgins A, Rudland PS, Campbell FC. El-Tanani M, et al. J Biol Chem. 2004 May 14;279(20):20794-806. doi: 10.1074/jbc.M311131200. Epub 2004 Feb 27. J Biol Chem. 2004. PMID: 14990565 Free article.

7

BRCA1 suppresses osteopontin-mediated breast cancer.

El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS. El-Tanani MK, et al. J Biol Chem. 2006 Sep 8;281(36):26587-601. doi: 10.1074/jbc.M604403200. Epub 2006 Jun 28. J Biol Chem. 2006. PMID: 16807234 Free article.

8

Identification of apolipoprotein D as a novel inhibitor of osteopontin-induced neoplastic transformation.

Jin D, El-Tanani M, Campbell FC. Jin D, et al. Int J Oncol. 2006 Dec;29(6):1591-9. Int J Oncol. 2006. PMID: 17089001

9

The regulation and role of osteopontin in malignant transformation and cancer.

El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. El-Tanani MK, et al. Cytokine Growth Factor Rev. 2006 Dec;17(6):463-74. doi: 10.1016/j.cytogfr.2006.09.010. Epub 2006 Nov 17. Cytokine Growth Factor Rev. 2006. PMID: 17113338 Review.

10

Interaction between transcription factor, basal transcription factor 3, and the NH2-terminal domain of human estrogen receptor alpha.

Green CD, Thompson PD, Johnston PG, El-Tanani MK. Green CD, et al. Mol Cancer Res. 2007 Nov;5(11):1191-200. doi: 10.1158/1541-7786.MCR-07-0123. Mol Cancer Res. 2007. PMID: 18025262 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters